Acute Graft-Versus-Host Disease (GVHD)

DBCOND0125377Immune System DiseasesWounds and Injuries

Acute Graft-Versus-Host Disease (GVHD) is the indication for 3 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Acute Graft Versus Host Disease · Acute GVH Disease · Acute GvHD · Acute Graft-Versus-Host Disease · Acute-graft-versus-host Disease
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10D89.810SNOMED CT402355000MedDRA10000802UMLSC0856825

What you can answer from here — as of October 06, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
135Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Acute Graft-Versus-Host Disease (GVHD) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In